Acamprosate (Campral®); Adolescents; Buprenorphine (extended-release, injectable); Brief intervention; Buprenorphine sub-dermal implant; Buprenorphine used in Treatment; Buprenorphine maintenance; Buprenorphine with naloxone; Buprenorphine without naloxone; Cash or self-payment; Cognitive behavioral therapy; Clonidine; Comprehensive mental health assessment; Contingency management/motivational incentives; Comprehensive substance use assessment; Drug or alcohol urine screening; Drug Enforcement Agency (DEA); Lofexidine or Clonidine detoxification; Disulfiram; Female; Group counseling; HIV or AIDS education, counseling, or support; Hepatitis A (HAV) vaccination; Testing for Hepatitis B (HBV); Naloxone and overdose education
Directory Details
Phone:
312-227-6800 x7805
Website:
https://www.luriechildrens.org/en/specialties-conditions/substance-use-prevention-program/
Services Detail:
Acamprosate (Campral®); Adolescents; Buprenorphine (extended-release, injectable); Brief intervention; Buprenorphine sub-dermal implant; Buprenorphine used in Treatment; Buprenorphine maintenance; Buprenorphine with naloxone; Buprenorphine without naloxone; Cash or self-payment; Cognitive behavioral therapy; Clonidine; Comprehensive mental health assessment; Contingency management/motivational incentives; Comprehensive substance use assessment; Drug or alcohol urine screening; Drug Enforcement Agency (DEA); Lofexidine or Clonidine detoxification; Disulfiram; Female; Group counseling; HIV or AIDS education, counseling, or support; Hepatitis A (HAV) vaccination; Testing for Hepatitis B (HBV); Naloxone and overdose education
Services:
treatment, mat, outpatient
Source:
SAMHSA FindTreatment (state download 2026-11-22)
Last Verified:
2026-11-22